263 related articles for article (PubMed ID: 16163669)
1. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.
Morishima Y; Ishii Y; Kimura T; Shibuya A; Shibuya K; Hegab AE; Iizuka T; Kiwamoto T; Matsuno Y; Sakamoto T; Nomura A; Taniguchi M; Sekizawa K
Eur J Immunol; 2005 Oct; 35(10):2803-14. PubMed ID: 16163669
[TBL] [Abstract][Full Text] [Related]
2. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
[TBL] [Abstract][Full Text] [Related]
3. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.
Hachem P; Lisbonne M; Michel ML; Diem S; Roongapinun S; Lefort J; Marchal G; Herbelin A; Askenase PW; Dy M; Leite-de-Moraes MC
Eur J Immunol; 2005 Oct; 35(10):2793-802. PubMed ID: 16180255
[TBL] [Abstract][Full Text] [Related]
4. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553
[TBL] [Abstract][Full Text] [Related]
5. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.
Lee KA; Kang MH; Lee YS; Kim YJ; Kim DH; Ko HJ; Kang CY
Cell Immunol; 2008 Jan; 251(1):50-5. PubMed ID: 18423430
[TBL] [Abstract][Full Text] [Related]
6. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
7. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
8. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
[TBL] [Abstract][Full Text] [Related]
9. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.
Hammad H; de Vries VC; Maldonado-Lopez R; Moser M; Maliszewski C; Hoogsteden HC; Lambrecht BN
Clin Exp Allergy; 2004 Dec; 34(12):1834-40. PubMed ID: 15663556
[TBL] [Abstract][Full Text] [Related]
10. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
11. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
[TBL] [Abstract][Full Text] [Related]
12. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
13. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
14. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
Fukushima A; Sumi T; Fukuda K; Yamaguchi T; Kumagai N; Nishida T; Ueno H
Immunol Lett; 2006 Sep; 107(1):32-40. PubMed ID: 16930723
[TBL] [Abstract][Full Text] [Related]
15. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production.
Hayashi N; Yoshimoto T; Izuhara K; Matsui K; Tanaka T; Nakanishi K
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14765-70. PubMed ID: 17766435
[TBL] [Abstract][Full Text] [Related]
16. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of intratracheal administration of murine IL-4 receptor antagonist on asthmatic airway inflammation.
Tian D; Fu Z; Liu E; He Y; Wang X; Wang L
J Asthma; 2008 Oct; 45(8):715-21. PubMed ID: 18951266
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory DNA mediates inhibition of eosinophilic inflammation and airway hyperreactivity independent of natural killer cells in vivo.
Broide DH; Stachnick G; Castaneda D; Nayar J; Miller M; Cho J; Rodriquez M; Roman M; Raz E
J Allergy Clin Immunol; 2001 Nov; 108(5):759-63. PubMed ID: 11692101
[TBL] [Abstract][Full Text] [Related]
20. The effect of overexpression of endothelial nitric oxide synthase on eosinophilic lung inflammation in a murine model.
Kobayashi K; Nishimura Y; Yamashita T; Nishiuma T; Satouchi M; Yokoyama M
Int Immunopharmacol; 2006 Jul; 6(7):1040-52. PubMed ID: 16714207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
